KLHL14: A Potential Drug Target for Various Diseases (G57565)

Target Name: KLHL14

NCBI ID: G57565

KLHL14

KLHL14: A Potential Drug Target for Various Diseases

KLHL14, also known as Kelch-like 14, is a protein that is expressed in various tissues throughout the body. It is a member of the Kelch family of proteins, which are involved in cell signaling and cytoskeletal organization. KLHL14 is unique due to its highly conserved sequence and its ability to interact with a variety of signaling molecules.

Recent studies have identified KLHL14 as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is due to KLHL14's involvement in several cellular processes that are associated with the development and progression of these diseases.

One of the key mechanisms by which KLHL14 is involved in disease is its role in the regulation of cell signaling pathways. KLHL14 has been shown to play a role in several signaling pathways that are involved in cell growth, differentiation, and survival. For example, KLHL14 has been shown to be involved in the regulation of the TGF-β pathway, which is involved in cell signaling and growth.

In addition to its role in cell signaling, KLHL14 has also been shown to be involved in the regulation of cytoskeletal organization. KLHL14 is a member of the Kelch family of proteins, which are involved in the regulation of cytoskeletal structure and dynamics. This makes KLHL14 a potential target for drugs that are designed to modulate cytoskeletal organization and contribute to the development of diseases such as cancer.

Another potential mechanism by which KLHL14 is involved in disease is its role in the regulation of inflammation. KLHL14 has been shown to play a role in the regulation of immune cell function and the production of inflammatory cytokines. This makes KLHL14 a potential target for drugs that are designed to prevent or alleviate the symptoms of inflammatory diseases.

In conclusion, KLHL14 is a protein that is involved in several cellular processes that are associated with the development and progression of various diseases. Its unique structure and conserved sequence make it a potential drug target for a variety of diseases. Further research is needed to fully understand the role of KLHL14 in disease and to develop effective treatments.

Protein Name: Kelch Like Family Member 14

The "KLHL14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KLHL14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets